Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Rev Med Interne ; 27(7): 546-9, 2006 Jul.
Artigo em Francês | MEDLINE | ID: mdl-16678940

RESUMO

INTRODUCTION: Adult onset Still's disease is a systemic inflammatory disorder of unknown etiology characterized by the association of a high spiking fever, an evanescent skin rash, arthritis, and hyperleukocytosis. Pericarditis is amongst the most common systemic manifestations of adult onset Still's disease. EXEGESIS: We report on two patients with a pericardial tamponade revealing an adult onset Still's disease in a 52-year-old female and a 31-year-old male. Pericardial fluid was bloody in the two cases, and histopathology only disclosed non specific inflammatory changes. Both patients received corticosteroids and outcome was uneventful with a follow-up of 8 years and 12 months, respectively. CONCLUSION: Pericardial tamponade is an uncommon clinical feature of adult-onset Still's disease and usually occurs at disease onset. It makes the diagnosis of adult-onset Still's disease difficult as the other disease manifestations are commonly neglected. Adult onset Still's disease should be added to the differential of acute pericarditis and tamponade.


Assuntos
Tamponamento Cardíaco/diagnóstico , Doença de Still de Início Tardio/diagnóstico , Adulto , Anti-Inflamatórios/uso terapêutico , Feminino , Seguimentos , Glucocorticoides/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Derrame Pericárdico/diagnóstico , Pericardite/diagnóstico , Prednisona/uso terapêutico , Doença de Still de Início Tardio/tratamento farmacológico
2.
Clin Infect Dis ; 41(2): e22-6, 2005 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-15983907

RESUMO

Diffuse infiltrative lymphocytosis syndrome (DILS) in patients with human immunodeficiency virus (HIV) infection is characterized by persistent CD8(+) lymphocytosis with visceral lymphocytic infiltration. DILS induces a large spectrum of clinical features. We describe 2 HIV-infected patients with upper respiratory tract involvement that occurred during the course of DILS.


Assuntos
Infecções por HIV/complicações , Linfocitose/etiologia , Doenças Respiratórias/etiologia , Adulto , Fármacos Anti-HIV/uso terapêutico , Linfócitos T CD8-Positivos , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/virologia , Humanos
3.
J Antimicrob Chemother ; 59(6): 1076-83, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17468115

RESUMO

OBJECTIVES: A patient with Candida albicans thrush and oesophagitis was treated with high doses of caspofungin but treatment eventually failed. Four C. albicans isolates were serially recovered before and after caspofungin treatment. A microbiological study was performed to characterize these four isolates. METHODS: In vitro antifungal susceptibility testing was performed by the EUCAST reference method in RPMI and AM3 and by Etest. Molecular typing of the four isolates was done by sizing three polymorphic microsatellite markers. To look for specific mutations, sequencing of a region of the gene encoding the 1-3-beta-D-glucan synthase was performed for the four isolates. RESULTS: In vitro antifungal susceptibility testing showed an increase in both caspofungin and micafungin MICs for the two isolates recovered after caspofungin treatment failure. The best discrimination between the pre-treatment and post-treatment isolates was obtained with Etest. Molecular typing of the four isolates showed that the post-treatment isolates with reduced susceptibility were identical to a susceptible pre-treatment isolate, suggesting the acquisition of caspofungin resistance. Sequencing of the gene encoding the 1-3-beta-D-glucan synthase showed a mutation responsible for an amino acid change at Phe-641 that could confer reduced susceptibility to both echinocandins. CONCLUSIONS: Our results indicate that is it useful to perform in vitro susceptibility testing in the cases of clinical failure during caspofungin therapy.


Assuntos
Antifúngicos/farmacologia , Candida albicans/efeitos dos fármacos , Candidíase/tratamento farmacológico , Farmacorresistência Fúngica/fisiologia , Lipoproteínas/farmacologia , Peptídeos Cíclicos/farmacologia , Adulto , Sequência de Aminoácidos , Substituição de Aminoácidos , Anfotericina B/farmacologia , Antifúngicos/uso terapêutico , Candidíase/microbiologia , Caspofungina , Equinocandinas , Fluconazol/farmacologia , Genótipo , Infecções por HIV/complicações , HIV-1 , Humanos , Lipopeptídeos , Lipoproteínas/uso terapêutico , Masculino , Micafungina , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Peptídeos Cíclicos/uso terapêutico , Pirimidinas/uso terapêutico , Falha de Tratamento , Triazóis/uso terapêutico , Voriconazol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA